RAFAEL MARÍA
CANTÓN MORENO
Profesor asociado
Patricia
Ruiz Garbajosa
Publications dans lesquelles il/elle collabore avec Patricia Ruiz Garbajosa (79)
2024
-
A long-term survey of Serratia spp. bloodstream infections revealed an increase of antimicrobial resistance involving adult population
Microbiology Spectrum, Vol. 12, Núm. 2
-
Evolution of ceftazidime-avibactam and cefiderocol resistance in ST131-H30R1-Escherichia coli isolates with KPC-3 mutants and application of FTIR biotyping
Microbiology Spectrum, Vol. 12, Núm. 4
-
In vitro activity of cefiderocol and other newly approved antimicrobials against multi-drug resistant Gram-negative pathogens recovered in intensive care units in Spain and Portugal
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 37, Núm. 1, pp. 69-77
2023
-
Automatic Discrimination of Species within the Enterobacter cloacae Complex Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Supervised Algorithms
Journal of clinical microbiology, Vol. 61, Núm. 4, pp. e0104922
-
Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the diagnosis and antimicrobial treatment of infections due to carbapenem-resistant Gram-negative bacteria
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 6, pp. 360-370
-
Outbreak by KPC-62-producing ST307 Klebsiella pneumoniae isolates resistant to ceftazidime/avibactam and cefiderocol in a university hospital in Madrid, Spain
Journal of Antimicrobial Chemotherapy, Vol. 78, Núm. 5, pp. 1259-1264
-
Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA)
eClinicalMedicine, Vol. 57
-
Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project)
The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 9, pp. 2291-2296
-
Treatment guidelines for multidrug-resistant Gram-negative microorganisms
Revista Espanola de Quimioterapia, Vol. 36, pp. 46-51
2022
-
Antibacterial spectrum of cefiderocol
Revista Espanola de Quimioterapia, Vol. 35, pp. 20-27
-
Carbapenemase-producing Enterobacterales infections in COVID-19 patients
Infectious Diseases, Vol. 54, Núm. 1, pp. 36-45
-
Correction to: Evaluation of CHROMagar™-Serratia agar, a new chromogenic medium for the detection and isolation of Serratia marcescens (European Journal of Clinical Microbiology & Infectious Diseases, (2021), 40, 12, (2593-2596), 10.1007/s10096-021-04328-w)
European Journal of Clinical Microbiology and Infectious Diseases
-
Impact of Ceftazidime-Avibactam Treatment in the Emergence of Novel KPC Variants in the ST307-Klebsiella pneumoniae High-Risk Clone and Consequences for Their Routine Detection
Journal of clinical microbiology, Vol. 60, Núm. 3, pp. e0224521
-
In Vitro Activity of Cefepime-Taniborbactam against Carbapenemase-Producing Enterobacterales and Pseudomonas aeruginosa Isolates Recovered in Spain
Antimicrobial Agents and Chemotherapy, Vol. 66, Núm. 3
2021
-
A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?
Infectious Diseases and Therapy, Vol. 10, Núm. 4, pp. 2677-2699
-
Characterization of carbapenemase-producing Serratia marcescens and whole-genome sequencing for plasmid typing in a hospital in Madrid, Spain (2016-18)
Journal of Antimicrobial Chemotherapy, Vol. 76, Núm. 1, pp. 110-116
-
Covid-19: Impact on prescribing and antimicrobial resistance
Revista Espanola de Quimioterapia, Vol. 34, pp. 63-68
-
Emergence and Persistence over Time of Carbapenemase-Producing Enterobacter Isolates in a Spanish University Hospital in Madrid, Spain (2005-2018)
Microbial Drug Resistance, Vol. 27, Núm. 7, pp. 895-903
-
Emergence of the new kpc-49 variant conferring an esbl phenotype with resistance to ceftazidime-avibactam in the st131-h30r1 escherichia coli high-risk clone
Pathogens, Vol. 10, Núm. 1, pp. 1-10
-
Etiology and antimicrobial susceptibility profiles of anaerobic bacteria isolated from clinical samples in a university hospital in Madrid, Spain
Anaerobe, Vol. 72